XessCore

by NeuroXessCN

A fully implanted wireless BCI with flexible electrodes and chest battery. Wireless transmission avoids infection-prone ports. Tested in patient with spinal cord injury.

PilotStage 3 of 5

Pilot testing: patient achieved cursor control in 5 days. Factory production target H2 2026.

Updated 14 Jan 2026Checked 10 Oct0 updates this week

Milestones

Next · Mass production begins (target)
  1. Company founded2021Complete.
  2. Series A funding from Zhongping and SequoiaDec 2022Complete.
  3. Over 50 human BCI surgeries completed2025Complete.
  4. First fully implanted battery-powered BCI in China completedDec 2025Complete.
  5. Super factory groundbreaking in JiangxiMar 2026Complete.
  6. Mass production begins (target)Target Q3 2026Not yet reached.
Primer